tobacco

Two new tobacco cessation medicines added to the WHO essential medicines list

Every two years, the World Health Organization (WHO) publishes its Model List of Essential Medicines (EML), a collection of medicines considered essential by WHO experts. The purpose of the list is to guide national authorities on the type of medicines that should be available in the country. On the 1st of October, the WHO introduced two new medicines classed as essential medicine for people who wish to stop using tobacco. Bupropion and varenicline are medicines

Cannabis and tobacco use prior to pregnancy and subsequent offspring birth outcomes: a 20-year intergenerational prospective cohort study

Citation
Hines, L.A., Spry, E.A., Moreno-Betancur, M. et al. Cannabis and tobacco use prior to pregnancy and subsequent offspring birth outcomes: a 20-year intergenerational prospective cohort study. Sci Rep 11, 16826 (2021). https://doi.org/10.1038/s41598-021-95460-2
Publication Date
Abstract

There is increasing evidence that the life-course origins of health and development begin before conception. We examined associations between timing and frequency of preconception cannabis and tobacco use and next generation preterm birth (PTB), low birth weight (LBW) and small for gestational age.

Tobacco Control in Africa

The World Health Organisation (WHO) estimates that one in five African adolescents use tobacco and predict a doubling of deaths related to tobacco use in low- and middle-income countries between 2002 and 2030. Here, you can find out more about policy and practice that countries are putting in place in an attempt to control tobacco use in Africa.

Call for Papers: Identifying and Eliminating Inequities in Tobacco Use and Related Health Outcomes

Nicotine & Tobacco Research intends to publish a themed issue on identifying and eliminating inequities in tobacco use and related health outcomes. This themed issue will consist of a collection of original articles exploring the causes of disparities in commercial tobacco use and its health impacts to inform pro-equity practice and strategies from the clinical to the population level.

Preventing Tobacco Use Among Youth: Evidence-Based Interventions

Ho Chi Minh City, Vietnam,
The global data indicates that the age of starting tobacco usage is decreasing rapidly. This not only has been causing many serious health consequences but is also increasing a lot of social issues. On the other hand, early use shows a high risk of leading to the use of other substances such as heroin in adulthood. Therefore, prevention and early intervention in this population are very crucial. In order to contribute to promoting the youth tobacco use prevention program in the near future in Vietnam, VHATTC organizes an online session on "Preventing Tobacco Use Among Youth: Evidence-Based Interventions".

Call for Abstracts: Society For Research On Nicotine and Tobacco

The Annual Meeting will be held on March 2-5 2022, and is currently scheduled to take place at the Edinburgh International Conference Center in Edinburgh, Scotland. The SRNT 2022 Annual Meeting may be a hybrid (part in person, part virtual) or entirely virtual, depending on how things play out in the coming months. A final decision about the meeting format (face-to-face hybrid virtual component vs. entirely virtual) will not be made for some time. In

SRNT 28th Annual Meeting

Edinburgh,

The Society of Research on Nicotine and Tobacco (SRNT) 2022 Annual Meeting may be a hybrid (part in person, part virtual) or entirely virtual, depending on how things play out in the coming months.

The event will take place in Edinburgh, Scotland from the 2-5th of March 2022.

Abstract submissions will open on July 7, 2021, and will close on August 11, 2021. 

Reporting treatment fidelity in behavioral tobacco treatment clinical trials: scoping review and measurement recommendations

Citation
Ramzi G Salloum, Alana M Rojewski, Megan E Piper, Janice A Blalock, Belinda Borrelli, Lindsay M Boyce, Jennifer A Minnix, Omara Dogar, Rachel L Tomko, Douglas E Jorenby, Chris Kotsen, Jamie S Ostroff, Treatment Fidelity Workgroup of the SRNT Treatment Network, Reporting Treatment Fidelity in Behavioral Tobacco Treatment Clinical Trials: Scoping Review and Measurement Recommendations, Nicotine & Tobacco Research, 2021;, ntab140, https://doi.org/10.1093/ntr/ntab140
Publication Date

Abstract

Introduction:

Tobacco Smoking and Associated Factors Among People Living With HIV in Uganda

Citation
Noreen Dadirai Mdege, PhD, Fredrick Edward Makumbi, PhD, Ronald Ssenyonga, MSc, Frances Thirlway, PhD, Joseph K B Matovu, PhD, Elena Ratschen, PhD, Kamran Siddiqi, PhD, Kellen Nyamurungi Namusisi, MSc, Tobacco Smoking and Associated Factors Among People Living With HIV in Uganda, Nicotine & Tobacco Research, Volume 23, Issue 7, July 2021, Pages 1208–1216, https://doi.org/10.1093/ntr/ntaa262

Rates of smoking among people living with HIV are greater than the number of people who smoke within the general population.

This article, published in the Journal of Nicotine and Tobacco, examines the smoking patterns and behaviours of people living with HIV and who are receiving care in Uganda.